126 related articles for article (PubMed ID: 27975069)
1. The Suppressed Induction of Human Mature Cytotoxic T Lymphocytes Caused by Asbestos Is Not due to Interleukin-2 Insufficiency.
Kumagai-Takei N; Nishimura Y; Matsuzaki H; Lee S; Yoshitome K; Hayashi H; Otsuki T
J Immunol Res; 2016; 2016():7484872. PubMed ID: 27975069
[TBL] [Abstract][Full Text] [Related]
2. Effect of IL-15 addition on asbestos-induced suppression of human cytotoxic T lymphocyte induction.
Kumagai-Takei N; Nishimura Y; Matsuzaki H; Lee S; Yoshitome K; Ito T; Otsuki T
Environ Health Prev Med; 2021 Apr; 26(1):50. PubMed ID: 33874885
[TBL] [Abstract][Full Text] [Related]
3. Effect of asbestos exposure on differentiation of cytotoxic T lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells.
Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Hiratsuka J; Otsuki T
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):28-36. PubMed ID: 23449737
[TBL] [Abstract][Full Text] [Related]
4. Effect of asbestos exposure on differentiation and function of cytotoxic T lymphocytes.
Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Yoshitome K; Ito T; Otsuki T
Environ Health Prev Med; 2020 Oct; 25(1):59. PubMed ID: 33032525
[TBL] [Abstract][Full Text] [Related]
5. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
6. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
7. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
Saijo Y; Hong X; Tanaka M; Tazawa R; Liu SQ; Saijo K; Ohno T; Koike K; Ohkuda K; Satoh K; Nukiwa T
Clin Cancer Res; 1999 May; 5(5):1203-9. PubMed ID: 10353758
[TBL] [Abstract][Full Text] [Related]
8. Development of precytotoxic T cells in cyclosporine-suppressed mixed lymphocyte reactions.
Hooton JW; Miller CL; Helgason CD; Bleackley RC; Gillis S; Paetkau V
J Immunol; 1990 Feb; 144(3):816-23. PubMed ID: 2136900
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors.
Chouaib S; Chehimi J; Bani L; Genetet N; Tursz T; Gay F; Trinchieri G; Mami-Chouaib F
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12659-63. PubMed ID: 7809096
[TBL] [Abstract][Full Text] [Related]
10. IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8
Li L; Jay SM; Wang Y; Wu SW; Xiao Z
Sci Rep; 2017 Oct; 7(1):13365. PubMed ID: 29042682
[TBL] [Abstract][Full Text] [Related]
11. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ regulatory T cells attenuate the phosphatidylinositol 3-kinase/Akt pathway in antigen-primed immature CD8+ CTLs during functional maturation.
Kojima H; Kanno Y; Hase H; Kobata T
J Immunol; 2005 May; 174(10):5959-67. PubMed ID: 15879088
[TBL] [Abstract][Full Text] [Related]
13. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.
Okada M; Kitahara M; Kishimoto S; Matsuda T; Hirano T; Kishimoto T
J Immunol; 1988 Sep; 141(5):1543-9. PubMed ID: 3261754
[TBL] [Abstract][Full Text] [Related]
14. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
[TBL] [Abstract][Full Text] [Related]
15. IL-10: a novel cytotoxic T cell differentiation factor.
Chen WF; Zlotnik A
J Immunol; 1991 Jul; 147(2):528-34. PubMed ID: 1906502
[TBL] [Abstract][Full Text] [Related]
16. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
[TBL] [Abstract][Full Text] [Related]
17. Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity.
Sutton VR; Brennan AJ; Ellis S; Danne J; Thia K; Jenkins MR; Voskoboinik I; Pejler G; Johnstone RW; Andrews DM; Trapani JA
FEBS J; 2016 Mar; 283(5):947-61. PubMed ID: 26756195
[TBL] [Abstract][Full Text] [Related]
18. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
[TBL] [Abstract][Full Text] [Related]
19. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
